These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7294555)

  • 1. Right ventricular unloading: lessons from the left.
    Franciosa JA; Fischer HA
    Ann Intern Med; 1981 Nov; 95(5):647-8. PubMed ID: 7294555
    [No Abstract]   [Full Text] [Related]  

  • 2. Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators?
    Rich S
    Cardiovasc Clin; 1990; 21(1):265-74; discussion 275-6. PubMed ID: 2199052
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasodilator therapy for pulmonary hypertensive disorders.
    Hyman AL; Kadowitz PJ
    Chest; 1984 Feb; 85(2):145-7. PubMed ID: 6692692
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards.
    Packer M
    Ann Intern Med; 1985 Aug; 103(2):258-70. PubMed ID: 2861770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for primary pulmonary hypertension. Back to the future.
    McManigle JE; Tenholder MF
    Chest; 1989 Oct; 96(4):900-5. PubMed ID: 2676396
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sildenafil improves right ventricular function in a cardiac transplant recipient].
    Paez RP; Araujo WF; Hossne NA; Neves AL; Vargas GF; Aguiar Lde F; Branco JN; Catani R; Buffolo E
    Arq Bras Cardiol; 2005 Feb; 84(2):176-8. PubMed ID: 15761645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilators and pulmonary hypertension: where do we go from here?
    Rubin LJ
    Am Rev Respir Dis; 1987 Feb; 135(2):287. PubMed ID: 3813188
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of heart failure in pulmonary arterial hypertension--the urgency of getting this right.
    Baliga RR; Young JB
    Heart Fail Clin; 2012 Jul; 8(3):xiii-xix. PubMed ID: 22748909
    [No Abstract]   [Full Text] [Related]  

  • 9. The case for treatment of selected patients with primary pulmonary hypertension.
    Davila F
    Am Rev Respir Dis; 1986 Dec; 134(6):1336-7. PubMed ID: 3789537
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular effects of vasodilator therapy for pulmonary arterial hypertension.
    Rubin LJ
    Clin Chest Med; 1983 May; 4(2):309-19. PubMed ID: 6342925
    [No Abstract]   [Full Text] [Related]  

  • 11. What might be learned from acute pulmonary vasodilator testing in portopulmonary hypertension?
    Swanson KL
    Liver Transpl; 2007 Nov; 13(11):1498-9. PubMed ID: 17969195
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of vasodilators prostaglandin E1 and methylprednisolone on pulmonary hypertension and right ventricular performance during volume loading in porcine septic shock: a combined invasive and radionuclide study.
    Schneider AJ; Teule GJ; Kester AD; van Halderen P; Groeneveld AB; Heidendal GA; Thijs LG
    Circ Shock; 1987; 22(2):141-54. PubMed ID: 3297378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilator therapy for primary pulmonary hypertension.
    McGoon MD; Vlietstra RE
    Mayo Clin Proc; 1984 Oct; 59(10):672-7. PubMed ID: 6148467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous epoprostenol for primary pulmonary hypertension.
    Schulze-Neick I; Lange PE; Haas NA
    N Engl J Med; 1996 May; 334(22):1477; author reply 1477-8. PubMed ID: 8618596
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemodynamic requirements for an ideal pulmonary vasodilator.
    Widimský J; Morpurgo M; Jezek V
    Eur Heart J; 1988 Sep; 9 Suppl J():23-8. PubMed ID: 3053181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basic principles of the current treatment of primary pulmonary hypertension].
    Konopleva LF; Revutskiĭ EL; Previr VN
    Kardiologiia; 1984 Oct; 24(10):121-5. PubMed ID: 6394865
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study.
    Morelli A; Teboul JL; Maggiore SM; Vieillard-Baron A; Rocco M; Conti G; De Gaetano A; Picchini U; Orecchioni A; Carbone I; Tritapepe L; Pietropaoli P; Westphal M
    Crit Care Med; 2006 Sep; 34(9):2287-93. PubMed ID: 16791109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
    Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary vasoreactivity testing in diagnosis and prognosis of pulmonary hypertension].
    Mutlu B; Hünük B; Kivrak T
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():43-9. PubMed ID: 20819766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury.
    Jacobs BR; Brilli RJ; Ballard ET; Passerini DJ; Smith DJ
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1536-42. PubMed ID: 9817705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.